single irb survey summary results
TRANSCRIPT
SINGLE IRB SURVEY SUMMARY RESULTSApril 17, 2018
NYU Clinical and Translational Science Institute (CTSI)NYU School of Medicine – Institutional Review Board
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
2
vSurvey Duration: 01/26/2018 – 02/28/2018
vSurvey Platform: REDCap
vTotal Number of Participants: 122q108 completed survey recordsq14 not completed survey records
General Information
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
3
Participating Institutions
vTotal of 105 Unique institutions participated in the survey
q15 Institutions are not affiliated with the CTSA
q59 CTSA Affiliated Institutions
q31 Not sure responses
No, 15
Not sure, 31Yes, 59
Is your institution affiliated with a CTSA?
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
4
Participating CTSA Institutions
v Albert Einstein (2)v Boston University (1)v Case Western Reserve University (1)v Columbia University (1)v Georgetown University (1)v Harvard University (1)v Indiana University Purdue University (1)v Johns Hopkins University (1)v Mayo Clinic (2)v Ohio State University (6)v Oregon Health & Science University (2)v Rockefeller University (1)v Stanford University (1)v University of California Davis (2)v University of California Irvine (1)v University of California Los Angeles (3)v University of California San Diego (1)v University of California San Francisco (2)
v University of Chicago (1)v University of Colorado (1)v University of Florida (2)v University of Illinois (3)v University of Massachusetts (1)v University of Miami (1)v University of Michigan (1)v University of North Carolina (1)v University of Rochester (1)v University of Southern California (1)v University of Texas Dallas (1)v University of Texas Houston (2)v University of Texas San Antonio (3)v University of Utah (3)v University of Washington (3)v Vanderbilt University (1)v Virginia Commonwealth University (2)v Wake Forest University (1)
(number of participants per institutions)
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
5
Section I. Administrative Information
Not sure, 3
Yes, 105
Does your institution have a Federal Wide Assurance?
No, 8 Not sure, 2
Yes, 98
Is your institution accredited by AAHRPP?
No, 2 Pending, 5
Yes, 101
Does your institute have an executed agreement with SMART IRB?
No, 2 Not sure, 2
Yes, 104
Does your IRB also act as the institutional privacy board?
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
6
Section I. Administrative Information
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
7
Section I. Administrative Information
If yes, which eIRB Platform?v Click/Huron (10)v iMedRIS (16)v InfoEd (12)v IRBManager (4)v IRBnet (35)v Key Solutions (8)v Other (9)
q Developed at UCI (1)q eProtocol (1)q home grown system (2)q home made 'BuckIRB’ (1)q HS FOX Database (1)q Kuali Coeus IRB (1)q Rascal (home-grown) (1)q homegrown IRB IS system (1)
No, 3Not sure,
11
Yes, 94
Does your institution use an electronic IRB system (eIRB)?
(number of participant responses)**All No or Not Sure responders indicated that they are willing to use an eIRB
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
8
Section I. Administrative Information
No, 1 Not sure, 1
Yes, 92
For institutions using an eIRBplatform: Has your eIRB been
customized to the specific needs of your institution?
42
42
7
1
0 20 40
Basic modifications: customquestion fields, new question fields,etc.
Complex modifications: we can addwhole new submission forms, wholeadditional pages, integrate with oursingle sign-on system, etc.
Very simple modifications: logo, picklists
Other
describe how extensively your electronic IRB system ('eIRB') can be modified:
NYU School of Medicine – Institutional Review Board
NYU Clinical and Translational Science Institute9
Section I. Administrative Information
No, 5
Not sure, 6
Yes, 82
Can your eIRB work with external systems (i.e. get live feed of your staff
lists from an HR system, receive updated training statuses from CITI, feed IRB approval status out to EPIC, etc.)?
No, 2 Not sure,
8
Yes, 72
Would you be interested using a public API
that allowed your eIRB to work with other
eIRBs to manage an NIH single IRB/multi-
site trial?
Section I. Administrative Information
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
10
No, 4
Not sure, 17
Yes, 87
Has your institution ever acted as an sIRB in the
past, or currently
Not sure, 2
1-5 times,
34
11-15 times,
7
6-10 times,
16
21+ times,
15
16-20 times,
13
If yes, how many times has your institution acted as sIRB in past
5 years?
1-5 participating sites, 14
11-15 participating
sites, 1
16-20 participating
sites, 10
21+ participating
sites, 48
6-10 participating sites, 9
Not sure, 5
If yes, what was the largest number of participating sites in the past 5
years?
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
11
Section II. IRB Review Volume
No, 15
Yes, 93
Does your institution receive IRB applications sponsored by the NIH?
NYU School of Medicine – Institutional Review Board
NYU Clinical and Translational Science Institute12
The goal of the following survey questions was to determine the amount of flexibility
requested/required for IRB study documents leading to the development of best
practices/standards for sIRB operations and efficient study startup.
Responses are:q Full sIRB Standardization - your site will accept sIRB standardized language/forms/processes
with no local IRB review (your local IRB will not review these instruments in order to adapt these
instruments to the local environment).
q Hybrid Approach - your site will be able to accept some sIRB standardized
language/forms/processes after local IRB review. (your local IRB will review these instruments
and may choose to modify some of these instruments for the local environment)
q Significant Local Modifications - your site requires review of all language/forms/processes and
would rarely approve a standardized (unmodified) study-wide instrument.
SECTION III – Assess Processes for Initial Evaluation of Protocol Documents and Protocol Modifications, and Tolerance for Process Standardization for sIRBParticipating Sites
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
13
SECTION III.A. Informed Consent Language
53%
55%
58%
65%
66%
66%
70%
72%
73%
79%
82%
92%
93%
44%
35%
42%
34%
33%
28%
29%
28%
26%
21%
18%
8%
7%
3%
10%
0%
1%
1%
6%
1%
0%
1%
0%
0%
0%
0%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Duration of participation
Risks or discomforts to the subject
Alternate procedures and courses of treatment
Purpose of research
Privacy Protection (HIPAA Authorization)
In case of injury explanation
Benefits to the subject
NIH Certificate of Confidentiality Statement
Research statement
Risks related to genetics research
Subject Remuneration (Subject Compensation)
Experimental procedures
Confidentiality of records
Full sIRB Standardization Hybrid Approach Significant Local Modifications
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
14
SECTION III.A.1. Informed Consent LanguageIf “hybrid” or “local”, who is responsible for local review (multiple choices allowed):
0 5 10 15 20 25 30 35 40 45 50
Research statement
Purpose of research
Duration of participation
Experimental procedures
Risks or discomforts to the subject
Risks related to genetics research
Benefits to the subject
Alternate procedures and courses of treatment
Confidentiality of records
Subject Remuneration (Subject Compensation)
In case of injury explanation
Privacy Protection (HIPAA Authorization)
NIH Certificate of Confidentiality Statement
Reliance Coordinator Legal Counsel Conflict of Interest Committee Compliance Officer IRB Director
NYU School of Medicine – Institutional Review Board
NYU Clinical and Translational Science Institute15
SECTION III.A.2. Informed Consent Language If “hybrid” or “local”, for any of the above, how many days are typically required for completion of institutional review/revision of study documents?
29%
22%
14%
7%
23%
30%
16%
17%
27%
24%
40%
50%
32%
57%
56%
65%
32%
18%
23%
47%
28%
25%
58%
23%
22%
21%
14%
22%
22%
43%
55%
43%
34%
47%
27%
12%
31%
25%
42%
0%
0…
0
18%
5%
3%
3%
8%
20%
6%
6%
3%
5%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Research statement
Purpose of research
Duration of participation
Experimental procedures
Risks or discomforts to the subject
Risks related to genetics research
Benefits to the subject
Alternate procedures and courses of treatment
Confidentiality of records
Subject Remuneration (Subject Compensation)
In case of injury explanation
Privacy Protection (HIPAA Authorization)
NIH Certificate of Confidentiality Statement
1 - 7 day/s 8 - 14 days 15 - 21 days 22+ days
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
16
SECTION III.B. Other IRB documents/ definitions
33%
49%
56%
74%
79%
54%
38%
44%
26%
21%
13%
13%
0%
0%
0%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Review of Conflict of Interests (Financial Disclosures)
Education, training and certifications (i.e. Human subjectstraining, good clinical practice, CITI modules)
Definition/Description of vulnerable populations
Review of Recruitment Materials
Data Safety Monitoring Plan/ Charter
Full sIRB Standardization Hybrid Approach Significant Local Modifications
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
17
SECTION III.B.1. Other IRB documents/ definitionsIf “hybrid” or “local”, who is responsible for local review (multiple choices allowed):
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70
Data Safety Monitoring Plan/ Charter
Definition/Description of vulnerable populations
Review of Conflict of Interests (FinancialDisclosures)
Education, training and certifications (i.e. Humansubjects training, good clinical practice, CITI
modules)
Review of Recruitment Materials
Reliance Coordinator Legal Counsel Conflict of Interest Committee Compliance Officer IRB Director
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
18
SECTION III.B.2. Other IRB documents/ definitionsIf “hybrid” or “local”, for any of the above, how many days are typically required for completion of institutional review/revision of study documents?
9%
13%
13%
32%
33%
9%
11%
31%
15%
30%
64%
44%
44%
40%
22%
18%
31%
11%
13%
15%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Data Safety Monitoring Plan/ Charter
Definition/Description of vulnerable populations
Review of Conflict of Interests (FinancialDisclosures)
Education, training and certifications (i.e. Humansubjects training, good clinical practice, CITI
modules)
Review of Recruitment Materials
1 - 7 day/s 8 - 14 days 15 - 21 days 22+ days
NYU School of Medicine – Institutional Review Board
NYU Clinical and Translational Science Institute19
The goal of the following survey questions was to determine the amount of flexibility
requested/required for IRB study documents leading to the development of best
practices/standards for sIRB operations and efficient study startup.
Responses are:q Full sIRB Standardization - your site will accept sIRB standardized language/forms/processes
with no local IRB review (your local IRB will not review these instruments in order to adapt these
instruments to the local environment).
q Hybrid Approach - your site will be able to accept some sIRB standardized
language/forms/processes after local IRB review. (your local IRB will review these instruments
and may choose to modify some of these instruments for the local environment)
q Significant Local Modifications - your site requires review of all language/forms/processes and
would rarely approve a standardized (unmodified) study-wide instrument.
SECTION IV – Assess Processes for Reportable Events and Subject Complaints, and Tolerance for Process Standardization for sIRB Participating Sites
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
20
SECTION IV. Reportable Events and Subject Complaints
33%
33%
57%
65%
63%
63%
39%
32%
4%
4%
4%
3%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Reporting Time Frame for subject complaints
Subject Complaint procedures
Reporting Time Frame for Reportable events
Defining IRB Reportable events
Full sIRB Standardization Hybrid Approach Significant Local Modifications
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
21
SECTION IV.1. Reportable Events and Subject ComplaintsIf “hybrid” or “local”, who is responsible for local review (multiple choices allowed):
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70
Defining IRB Reportable events
Reporting Time Frame for Reportable events
Subject Complaint procedures
Reporting Time Frame for subject complaints
Reliance Coordinator Legal Counsel Conflict of Interest Committee Compliance Officer IRB Director
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
22
SECTION IV.2. Reportable Events and Subject ComplaintsIf “hybrid” or “local”, for any of the above, how many days are typically required for completion of institutional review/revision of study documents?
19%
16%
23%
20%
27%
16%
29%
26%
41%
49%
41%
36%
14%
20%
7%
19%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Defining IRB Reportable events
Reporting Time Frame for Reportable events
Subject Complaint procedures
Reporting Time Frame for subject complaints
1 - 7 day/s 8 - 14 days 15 - 21 days 22+ days
NYU School of Medicine – Institutional Review Board
NYU Clinical and Translational Science Institute23
The goal of the following survey questions was to determine the amount of flexibility
requested/required for IRB study documents leading to the development of best
practices/standards for sIRB operations and efficient study startup.
Responses are:q Full sIRB Standardization - your site will accept sIRB standardized language/forms/processes
with no local IRB review (your local IRB will not review these instruments in order to adapt these
instruments to the local environment).
q Hybrid Approach - your site will be able to accept some sIRB standardized
language/forms/processes after local IRB review. (your local IRB will review these instruments
and may choose to modify some of these instruments for the local environment)
q Significant Local Modifications - your site requires review of all language/forms/processes and
would rarely approve a standardized (unmodified) study-wide instrument.
SECTION V – Assess Processes for Evaluation of Protocol Documents by Ancillary Committees and Tolerance for Process Standardization for sIRB Participating Sites
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
24
SECTION V. Evaluation of Protocol Documents by Ancillary Committees
55%
57%
62%
33%
31%
26%
13%
13%
13%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Outcomes of ancillary review(s) and process for re-review(s)
Timing of ancillary reviews
Defining ancillary reviews (i.e., confidentiality, risk mgmt., IBC,PRMC)
Full sIRB Standardization Hybrid Approach Significant Local Modifications
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
25
SECTION V.1. Evaluation of Protocol Documents by Ancillary CommitteesIf “hybrid” or “local”, who is responsible for local review (multiple choices allowed):
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70
Defining ancillary reviews (i.e., confidentiality,risk mgmt., IBC, PRMC)
Timing of ancillary reviews
Outcomes of ancillary review(s) and process forre-review(s)
Reliance Coordinator Legal Counsel Conflict of Interest Committee Compliance Officer IRB Director
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
26
SECTION V.2. Evaluation of Protocol Documents by Ancillary Committees If “hybrid” or “local”, for any of the above, how many days are typically required for completion of institutional review/revision of study documents?
28%
16%
19%
23%
27%
21%
45%
47%
45%
5%
11%
15%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Defining ancillary reviews (i.e., confidentiality, riskmgmt., IBC, PRMC)
Timing of ancillary reviews
Outcomes of ancillary review(s) and process forre-review(s)
1 - 7 day/s 8 - 14 days 15 - 21 days 22+ days
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
27
SECTION VI. Acceptance of Reliance Agreement for sIRB Participating Sites
No, 1 Not sure, 5
Yes, 100
Would your institution be willing to engage in a Reliance agreement with a sIRB?
NYU School of Medicine – Institutional Review Board
NYU Clinical and Translational Science Institute28
The goal of the following survey questions was to determine the amount of flexibility
requested/required for IRB study documents leading to the development of best
practices/standards for sIRB operations and efficient study startup.
Responses are:q Full sIRB Standardization - your site will accept sIRB standardized language/forms/processes
with no local IRB review (your local IRB will not review these instruments in order to adapt these
instruments to the local environment).
q Hybrid Approach - your site will be able to accept some sIRB standardized
language/forms/processes after local IRB review. (your local IRB will review these instruments
and may choose to modify some of these instruments for the local environment)
q Significant Local Modifications - your site requires review of all language/forms/processes and
would rarely approve a standardized (unmodified) study-wide instrument.
SECTION VI. Acceptance of Reliance Agreement for sIRB Participating Sites
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
29
SECTION VI. Acceptance of Reliance Agreement for sIRB Participating Sites
55%
55%
41%
37%
4%
8%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Indemnification Statement
Distribution of responsibilities
Full sIRB Standardization Hybrid Approach Significant Local Modifications
*Verification of human subjects training,review and management of conflicts ofinterest, management of changes in studypersonnel.
*Historically this has probably been themost difficult issue to address universally.In the past, issues where the ReviewingIRB has an indemnification agreement withlanguage inconsistent with the participatingsite's institutional requirements
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
30
SECTION VI.1. Acceptance of Reliance Agreement for sIRB Participating SitesIf “hybrid” or “local”, who is responsible for local review (multiple choices allowed):
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70
Indemnification Statement
Distribution of responsibilities
Reliance Coordinator Legal Counsel Conflict of Interest Committee Compliance Officer IRB Director
*Verification of human subjects training,review and management of conflicts ofinterest, management of changes in studypersonnel.
*Historically this has probably been themost difficult issue to address universally.In the past, issues where the ReviewingIRB has an indemnification agreement withlanguage inconsistent with the participatingsite's institutional requirements
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
31
SECTION VI.2. Acceptance of Reliance Agreement for sIRB Participating SitesIf “hybrid” or “local”, for any of the above, how many days are typically required for completion of institutional review/revision of study documents?
2%
29%
30%
22%
43%
33%
25%
16%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Indemnification Statement
Distribution of responsibilities
1 - 7 day/s 8 - 14 days 15 - 21 days 22+ days
*Verification of human subjects training,review and management of conflicts ofinterest, management of changes in studypersonnel.
*Historically this has probably been themost difficult issue to address universally.In the past, issues where the ReviewingIRB has an indemnification agreement withlanguage inconsistent with the participatingsite's institutional requirements
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
32
v We recognize that each survey participant’s responses to the survey questions may vary depending on whether their institution is joining a multisite study as the Participating Site or acting as the sIRB Primary Site of record for a multisite study. Therefore, we asked survey participants to provide their responses to the same series of questions as the sIRB Primary site of record for a multisite study. q Out of 108 survey participants who completed the survey
o 73 survey participants opted not to respond o 17 survey participants did respond to the question (missing response)o 18 survey participants provided their responses as the sIRB Primary site
Survey for sIRB Primary Sites
No, 73
Yes, 18
Missing response, 17
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
33
The goal of these survey questions is to determine the amount of flexibility requested/required for IRB study documents leading to the development of best practices/standards for sIRB operations and efficient study startup.Responses are:
q Full sIRB Standardization – as a primary site you would prefer participating sites to accept all sIRB standardized language/forms/processes with no local IRB review (the participating site’s local IRB will not review these instruments in order to adapt these instruments to the local environment).
q Hybrid Approach – as a primary site you would accept local review of sIRB standardized language/forms/processes and would allow modifications to some of these instruments. (the participating site’s local IRB will review these instruments and may choose to modify some of these instruments for the local environment)
q Significant Local Modifications – as a primary site you would allow the participating site’s local IRB to review all language/forms/processes in order to adapt all instruments to the local environment.
SECTION III (Primary Site) – Assess Processes for Initial Evaluation of Protocol Documents and Protocol Modifications, and Tolerance for Process Standardization for sIRB Primary
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
34
SECTION III (Primary Site).A. Informed Consent Language
7%
14%
36%
43%
64%
71%
79%
79%
79%
79%
86%
86%
86%
64%
57%
50%
43%
29%
21%
14%
14%
14%
14%
7%
7%
7%
29%
29%
14%
14%
7%
7%
7%
7%
7%
7%
7%
7%
7%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
In case of injury explanation
Privacy Protection (HIPAA Authorization)
Subject Remuneration (Subject Compensation)
Confidentiality of records
Alternate procedures and courses of treatment
NIH Certificate of Confidentiality Statement
Duration of participation
Experimental procedures
Risks related to genetics research
Benefits to the subject
Research statement
Purpose of research
Risks or discomforts to the subject
Full sIRB Standardization Hybrid Approach Significant Local Modifications
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
35
SECTION III (Primary Site).A.1. Informed Consent LanguageIf “hybrid” or “local”, who is responsible for local review (multiple choices allowed):
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
Research statement
Purpose of research
Duration of participation
Experimental procedures
Risks or discomforts to the subject
Risks related to genetics research
Benefits to the subject
Alternate procedures and courses of treatment
Confidentiality of records
Subject Remuneration (Subject Compensation)
In case of injury explanation
Privacy Protection (HIPAA Authorization)
NIH Certificate of Confidentiality Statement
Reliance Coordinator Legal Counsel Conflict of Interest Committee Compliance Officer IRB Director
NYU School of Medicine – Institutional Review Board
NYU Clinical and Translational Science Institute36
SECTION III (Primary Site).A.2. Informed Consent LanguageIf “hybrid” or “local”, for any of the above, how many days are typically required for completion of institutional review/revision of study documents?
0%
0%
33%
0%
0%
33%
33%
20%
29%
50%
25%
45%
25%
0%
0%
0%
0%
0%
0
0%
20%
29%
13%
42%
27%
0%
100%
100%
67%
100%
100%
67%
67%
60%
43%
38%
25%
27%
75%
0%
0…
0
0%
0%
0%
0%
0%
0%
0%
8%
0%
0%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Research statement
Purpose of research
Duration of participation
Experimental procedures
Risks or discomforts to the subject
Risks related to genetics research
Benefits to the subject
Alternate procedures and courses of treatment
Confidentiality of records
Subject Remuneration (Subject Compensation)
In case of injury explanation
Privacy Protection (HIPAA Authorization)
NIH Certificate of Confidentiality Statement
1 - 7 day/s 8 - 14 days 15 - 21 days 22+ days
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
37
SECTION III (Primary Site).B. Other IRB documents/ definitions
23%
31%
54%
62%
83%
38%
15%
38%
38%
8%
38%
54%
8%
0%
8%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Review of Conflict of Interests (Financial Disclosures)
Education, training and certifications (i.e. Human subjectstraining, good clinical practice, CITI modules)
Review of Recruitment Materials
Definition/Description of vulnerable populations
Data Safety Monitoring Plan/ Charter
Full sIRB Standardization Hybrid Approach Significant Local Modifications
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
38
SECTION III (Primary Site).B.1. Other IRB documents/ definitionsIf “hybrid” or “local”, who is responsible for local review (multiple choices allowed):
0 1 2 3 4 5 6 7 8 9 10
Data Safety Monitoring Plan/ Charter
Definition/Description of vulnerable populations
Review of Conflict of Interests (FinancialDisclosures)
Education, training and certifications (i.e. Humansubjects training, good clinical practice, CITI
modules)
Review of Recruitment Materials
Reliance Coordinator Legal Counsel Conflict of Interest Committee Compliance Officer IRB Director
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
39
SECTION III (Primary Site).B.2. Other IRB documents/ definitionsIf “hybrid” or “local”, for any of the above, how many days are typically required for completion of institutional review/revision of study documents?
0%
60%
20%
56%
33%
0%
0%
40%
11%
17%
100%
40%
30%
33%
50%
0%
0…
10%
0%
0%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Data Safety Monitoring Plan/ Charter
Definition/Description of vulnerable populations
Review of Conflict of Interests (FinancialDisclosures)
Education, training and certifications (i.e. Humansubjects training, good clinical practice, CITI
modules)
Review of Recruitment Materials
1 - 7 day/s 8 - 14 days 15 - 21 days 22+ days
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
40
The goal of these survey questions is to determine the amount of flexibility requested/required for IRB study documents leading to the development of best practices/standards for sIRB operations and efficient study startup.
Responses are:q Full sIRB Standardization – as a primary site you would prefer participating sites to accept all
sIRB standardized language/forms/processes with no local IRB review (the participating site’s local IRB will not review these instruments in order to adapt these instruments to the local environment).
q Hybrid Approach – as a primary site you would accept local review of sIRB standardized language/forms/processes and would allow modifications to some of these instruments. (the participating site’s local IRB will review these instruments and may choose to modify some of these instruments for the local environment)
q Significant Local Modifications – as a primary site you would allow the participating site’s local IRB to review all language/forms/processes in order to adapt all instruments to the local environment.
SECTION IV (Primary Site) – Assess Processes for Reportable Events and Subject Complaints, and Tolerance for Process Standardization for sIRB Primary Sites
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
41
SECTION IV (Primary Site). Reportable Events and Subject Complaints
54%
62%
85%
85%
46%
38%
15%
15%
0%
0%
0%
0%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Subject Complaint procedures
Reporting Time Frame for subject complaints
Defining IRB Reportable events
Reporting Time Frame for Reportable events
Full sIRB Standardization Hybrid Approach Significant Local Modifications
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
42
SECTION IV (Primary Site).1. Reportable Events and Subject ComplaintsIf “hybrid” or “local”, who is responsible for local review (multiple choices allowed):
0 1 2 3 4 5 6 7 8 9 10
Defining IRB Reportable events
Reporting Time Frame for Reportable events
Subject Complaint procedures
Reporting Time Frame for subject complaints
Reliance Coordinator Legal Counsel Conflict of Interest Committee Compliance Officer IRB Director
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
43
SECTION IV (Primary Site).2. Reportable Events and Subject ComplaintsIf “hybrid” or “local”, for any of the above, how many days are typically required for completion of institutional review/revision of study documents?
0%
0%
33%
40%
50%
50%
33%
40%
50%
50%
33%
20%
0%
0%
0%
0%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Defining IRB Reportable events
Reporting Time Frame for Reportable events
Subject Complaint procedures
Reporting Time Frame for subject complaints
1 - 7 day/s 8 - 14 days 15 - 21 days 22+ days
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
44
The goal of these survey questions is to determine the amount of flexibility requested/required for IRB study documents leading to the development of best practices/standards for sIRB operations and efficient study startup.Responses are:
q Full sIRB Standardization – as a primary site you would prefer participating sites to accept all sIRB standardized language/forms/processes with no local IRB review (the participating site’s local IRB will not review these instruments in order to adapt these instruments to the local environment).
q Hybrid Approach – as a primary site you would accept local review of sIRB standardized language/forms/processes and would allow modifications to some of these instruments. (the participating site’s local IRB will review these instruments and may choose to modify some of these instruments for the local environment)
q Significant Local Modifications – as a primary site you would allow the participating site’s local IRB to review all language/forms/processes in order to adapt all instruments to the local environment.
SECTION V (Primary Site) – Assess Processes for Evaluation of Protocol Documents by Ancillary Committees and Tolerance for Process Standardization for sIRB Primary Sites
NYU School of Medicine – Institutional Review Board
NYU Clinical and Translational Science Institute45
SECTION V (Primary Site). Evaluation of Protocol Documents by Ancillary Committees
23%
23%
23%
23%
23%
31%
54%
54%
46%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Defining ancillary reviews (i.e., confidentiality, risk mgmt., IBC,
PRMC)
Timing of ancillary reviews
Outcomes of ancillary review(s) and process for re-review(s)
Full sIRB Standardization Hybrid Approach Significant Local Modifications
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
46
SECTION V (Primary Site).1. Evaluation of Protocol Documents by Ancillary CommitteesIf “hybrid” or “local”, who is responsible for local review (multiple choices allowed):
0 1 2 3 4 5 6 7 8 9 10
Defining IRB Reportable events
Reporting Time Frame for Reportable events
Subject Complaint procedures
Reporting Time Frame for subject complaints
Reliance Coordinator Legal Counsel Conflict of Interest Committee Compliance Officer IRB Director
NYU School of Medicine – Institutional Review Board
NYU Clinical and Translational Science Institute
47
SECTION V (Primary Site).2. Evaluation of Protocol Documents by Ancillary Committees If “hybrid” or “local”, for any of the above, how many days are typically required for completion of institutional review/revision of study documents?
40%
30%
40%
30%
30%
30%
30%
30%
30%
0%
10%
0%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Defining ancillary reviews (i.e., confidentiality, risk
mgmt., IBC, PRMC)
Timing of ancillary reviews
Outcomes of ancillary review(s) and process for
re-review(s)
1 - 7 day/s 8 - 14 days 15 - 21 days 22+ days
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
48
SECTION VI (Primary Site). Acceptance of Reliance Agreement for sIRB Primary Sites
Not sure, 1
Yes, 15
Would your institution be willing to engage in a Reliance agreement with other participating sites?
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
49
The goal of these survey questions is to determine the amount of flexibility requested/required for IRB study documents leading to the development of best practices/standards for sIRB operations and efficient study startup.
Responses are:q Full sIRB Standardization – as a primary site you would prefer participating sites to accept all
sIRB standardized language/forms/processes with no local IRB review (the participating site’s local IRB will not review these instruments in order to adapt these instruments to the local environment).
q Hybrid Approach – as a primary site you would accept local review of sIRB standardized language/forms/processes and would allow modifications to some of these instruments. (the participating site’s local IRB will review these instruments and may choose to modify some of these instruments for the local environment)
q Significant Local Modifications – as a primary site you would allow the participating site’s local IRB to review all language/forms/processes in order to adapt all instruments to the local environment.
SECTION VI (Primary Site). Acceptance of Reliance Agreement for sIRB Primary Sites
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
50
SECTION (Primary Site). Acceptance of Reliance Agreement for sIRB Primary Sites
8%
15%
69%
46%
23%
38%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Indemnification Statement
Distribution of responsibilities
Full sIRB Standardization Hybrid Approach Significant Local Modifications
*Verification of human subjects training,review and management of conflicts ofinterest, management of changes in studypersonnel.
*Historically this has probably been themost difficult issue to address universally.In the past, issues where the ReviewingIRB has an indemnification agreement withlanguage inconsistent with the participatingsite's institutional requirements
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
51
SECTION VI (Primary Site).1. Acceptance of Reliance Agreement for sIRBPrimary SitesIf “hybrid” or “local”, who is responsible for local review (multiple choices allowed):
0 1 2 3 4 5 6 7 8 9 10
Indemnification Statement
Distribution of responsibilities
Reliance Coordinator Legal Counsel Conflict of Interest Committee Compliance Officer IRB Director
*Verification of human subjects training,review and management of conflicts ofinterest, management of changes in studypersonnel.
*Historically this has probably been themost difficult issue to address universally.In the past, issues where the ReviewingIRB has an indemnification agreement withlanguage inconsistent with the participatingsite's institutional requirements
NYU School of Medicine – Institutional Review BoardNYU Clinical and Translational Science Institute
52
SECTION VI (Primary Site).2. Acceptance of Reliance Agreement for sIRBPrimary SitesIf “hybrid” or “local”, for any of the above, how many days are typically required for completion of institutional review/revision of study documents?
0%
45%
58%
27%
33%
27%
8%
0%
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100%
Indemnification Statement
Distribution of responsibilities
1 - 7 day/s 8 - 14 days 15 - 21 days 22+ days
*Verification of human subjects training,review and management of conflicts ofinterest, management of changes in studypersonnel.
*Historically this has probably been themost difficult issue to address universally.In the past, issues where the ReviewingIRB has an indemnification agreement withlanguage inconsistent with the participatingsite's institutional requirements